Renal Function in Hypertensive Patients Receiving Cilnidipine and L-Type Calcium Channel Blockers: A Meta-Analysis of Randomized Controlled and Retrospective Studies

Nearly 65%-95% of chronic kidney disease (CKD) patients have hypertension. Calcium-channel blockers are the first-line drugs for the treatment of hypertension, including hypertension with diabetes. This study aims to estimate the effect of an L-type calcium channel blocker (CCB), cilnidipine, on the...

Descripción completa

Detalles Bibliográficos
Autores principales: Srivathsan, Mayakalyani, Vardhan, Vikram, Naseem, Azra, Patil, Sayali, Rai, Vivek, Langade, Deepakkumar G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461693/
https://www.ncbi.nlm.nih.gov/pubmed/36110460
http://dx.doi.org/10.7759/cureus.27847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461693/
https://www.ncbi.nlm.nih.gov/pubmed/36110460
http://dx.doi.org/10.7759/cureus.27847

Ejemplares similares